FI930718A - Loesliga salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)pyrimidin-5-karboxylsyra-(n-metyl-n-(3-trifluormetylfenyl)amid), foerfarande foer framstaellning av dessa, anvaendning av dessa som laekemedel och utgaongsaemnen - Google Patents

Loesliga salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)pyrimidin-5-karboxylsyra-(n-metyl-n-(3-trifluormetylfenyl)amid), foerfarande foer framstaellning av dessa, anvaendning av dessa som laekemedel och utgaongsaemnen Download PDF

Info

Publication number
FI930718A
FI930718A FI930718A FI930718A FI930718A FI 930718 A FI930718 A FI 930718A FI 930718 A FI930718 A FI 930718A FI 930718 A FI930718 A FI 930718A FI 930718 A FI930718 A FI 930718A
Authority
FI
Finland
Prior art keywords
dessa
pyrimidine
amide
dimethyl
amino
Prior art date
Application number
FI930718A
Other languages
English (en)
Other versions
FI105097B (fi
FI930718A0 (fi
Inventor
Klaus-Dieter Kampe
Ernold Granzer
Michael Leineweber
Manfred Huettinger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI930718A0 publication Critical patent/FI930718A0/fi
Publication of FI930718A publication Critical patent/FI930718A/fi
Application granted granted Critical
Publication of FI105097B publication Critical patent/FI105097B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30Oxygen or sulfur atoms
    • C07D233/32One oxygen atom
    • C07D233/38One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI930718A 1992-02-22 1993-02-18 Menetelmä terapeuttisesti käyttökelpoisen 4-amino-2-(4,4-dimetyyli-imidatsolidin-2-on-1-yyli)pyrimidiini-5-karboksyylihappo-[N-metyyli-N-(3-trifluorimetyylifenyyli)amidin] hydrokloridisuolan valmistamiseksi FI105097B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4205483 1992-02-22
DE4205483 1992-02-22

Publications (3)

Publication Number Publication Date
FI930718A0 FI930718A0 (fi) 1993-02-18
FI930718A true FI930718A (fi) 1993-08-23
FI105097B FI105097B (fi) 2000-06-15

Family

ID=6452363

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930718A FI105097B (fi) 1992-02-22 1993-02-18 Menetelmä terapeuttisesti käyttökelpoisen 4-amino-2-(4,4-dimetyyli-imidatsolidin-2-on-1-yyli)pyrimidiini-5-karboksyylihappo-[N-metyyli-N-(3-trifluorimetyylifenyyli)amidin] hydrokloridisuolan valmistamiseksi

Country Status (16)

Country Link
US (1) US5795899A (fi)
EP (1) EP0557877B1 (fi)
JP (1) JP3258744B2 (fi)
AT (1) ATE158581T1 (fi)
AU (2) AU658265B2 (fi)
CA (1) CA2089956A1 (fi)
DE (1) DE59307402D1 (fi)
DK (1) DK0557877T3 (fi)
ES (1) ES2109382T3 (fi)
FI (1) FI105097B (fi)
GR (1) GR3025235T3 (fi)
HU (1) HU210621B (fi)
IL (1) IL104792A (fi)
NO (1) NO300892B1 (fi)
NZ (2) NZ264767A (fi)
ZA (1) ZA931183B (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE147384T1 (de) * 1992-02-22 1997-01-15 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DE19625089A1 (de) * 1996-06-24 1998-01-02 Hoechst Ag 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE19625088A1 (de) * 1996-06-24 1998-01-02 Hoechst Ag 4-Amino-2-ureido-pyrimidin-5-carbonsäureamide, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
DE60025243T2 (de) * 1999-10-12 2006-06-22 Takeda Pharmaceutical Co. Ltd. Pyrimidin-5-carboximidverbindungen, verfahren zur herstellung derselben und deren verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853220A1 (de) * 1978-12-09 1980-07-03 Hoechst Ag Neue amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und ihre verwendung
DE3522940A1 (de) * 1985-06-27 1987-01-08 Hoechst Ag 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidin-5-carbonsaeure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln
ATE147384T1 (de) * 1992-02-22 1997-01-15 Hoechst Ag 4-amino-2-ureido-pyrimidin-5-carbonsäureamide, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung

Also Published As

Publication number Publication date
DE59307402D1 (de) 1997-10-30
IL104792A (en) 1997-09-30
JP3258744B2 (ja) 2002-02-18
CA2089956A1 (en) 1993-08-23
FI105097B (fi) 2000-06-15
NZ264767A (en) 1995-10-26
ATE158581T1 (de) 1997-10-15
AU658265B2 (en) 1995-04-06
HU9300459D0 (en) 1993-05-28
ES2109382T3 (es) 1998-01-16
AU669463B2 (en) 1996-06-06
AU1136595A (en) 1995-04-13
ZA931183B (en) 1993-09-16
DK0557877T3 (da) 1998-04-27
HU210621B (en) 1995-06-28
NZ245937A (en) 1994-12-22
EP0557877B1 (de) 1997-09-24
NO930595L (no) 1993-08-23
FI930718A0 (fi) 1993-02-18
NO300892B1 (no) 1997-08-11
EP0557877A1 (de) 1993-09-01
JPH06184137A (ja) 1994-07-05
HUT63410A (en) 1993-08-30
NO930595D0 (no) 1993-02-19
AU3376093A (en) 1993-08-26
GR3025235T3 (en) 1998-02-27
IL104792A0 (en) 1993-06-10
US5795899A (en) 1998-08-18

Similar Documents

Publication Publication Date Title
HUT67028A (en) Indole derivatives, pharmeceutical compositions comprising them and process for their production
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
NO301589B1 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, anvendelse derav og legemidler som inneholder forbindelsene
HK1018438A1 (en) Crystals of vitamin d derivatives and process for the preparation thereof
FI930718A (fi) Loesliga salter av 4-amino-2-(4,4-dimetyl-imidazolidin-2-on-1-yl)pyrimidin-5-karboxylsyra-(n-metyl-n-(3-trifluormetylfenyl)amid), foerfarande foer framstaellning av dessa, anvaendning av dessa som laekemedel och utgaongsaemnen
ES2147749T3 (es) Procedimiento para la preparacion de derivados de ciano-metoxiiminometilo.
PT93353A (pt) Processo para a producao de acidos aminoalcanodifosfinicos n-substituidos
GR3023711T3 (en) Method of preparation of 3-beta-aminocholanic acid derivatives.
YU48153B (sh) (2R,3S)-beta-FENILIZOSERIN, NJEGOVE SOLI I POSTUPAK DOBIVANJA(2R,3S)
ES2060854T3 (es) Procedimiento para la preparacion de acido 2-mercapto-4-metil-1,3-tiazol-5-il-acetico y sus esteres.
ZA924888B (en) Process for the synthesis of enantiomers of 3-aminochroman compounds
FR2742748B1 (fr) Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent
TNSN93081A1 (fr) Procede de preparation de derives de la n-(phenylethyl-b-ol) amine